Skip to Content

Join the 'Uterine Leiomyomata / Fibroids' group to help and get support from people like you.

Uterine Leiomyomata / Fibroids News

Related terms: Uterine Fibroid, Fibroid

Use of Cancer-Linked Fibroid Device Declines After FDA Warning

Posted 23 Aug 2016 by Drugs.com

TUESDAY, Aug. 23, 2016 – The use of power morcellators – cutting tools used in minimally invasive gynecological procedures – has dropped significantly for hysterectomies since the U.S. Food and Drug Administration warned against their use two years ago, a new study finds. Power morcellators have small blades that rotate rapidly. When used in minimally invasive hysterectomies or for the removal of noncancerous growths on the uterus known as fibroids, they slice the tissue into smaller pieces that are removed through a small opening in the abdomen. But tiny pieces of tissue can also spread to other areas of the body. And, sometimes, undetected cancers can be cut up with the healthy tissue. If that cancerous tissue isn't completely removed, those cells can cause cancer elsewhere. That's what prompted the FDA to issue its 2014 warning, the researchers explained. The new study looked only ... Read more

Related support groups: Surgery, Cancer, Hysterectomy, Ovarian Cancer, Uterine Leiomyomata / Fibroids, Genitourinary Surgical and Other Conditions, Urinary Tract Cancer

FDA OKs 'Containment' Bag for Certain Uterine Surgeries

Posted 7 Apr 2016 by Drugs.com

THURSDAY, April 7, 2016 – The U.S. Food and Drug Administration on Thursday said it would permit limited use of a "tissue containment system" in conjunction with laparoscopic power morcellators – devices that grind up tissue in gynecological surgeries. But the FDA still warns against using laparoscopic power morcellators in most women because the procedure can spread undetected cancer cells. The device, called the PneumoLiner, will be permitted only when uterine tissue is not suspected to contain cancer, the agency said. And its maker must warn patients and doctors that the device has not been proven to reduce the risk of spreading cancer during these procedures. "The PneumoLiner is intended to contain morcellated tissue in the very limited patient population for whom power morcellation may be an appropriate therapeutic option – and only if patients have been appropriately informed ... Read more

Related support groups: Surgery, Cancer, Abnormal Uterine Bleeding, Hysterectomy, Uterine Leiomyomata / Fibroids, Urinary Tract Cancer, Genitourinary Surgical and Other Conditions

Women's Sex Lives Get a Boost After Non-Surgical Fibroid Treatment

Posted 4 Apr 2016 by Drugs.com

MONDAY, April 4, 2016 – Women with bothersome uterine fibroids saw improvements in their sex lives and significant symptom relief a year after undergoing a type of non-surgical treatment called uterine fibroid embolization, a French study finds. Nearly eight in 10 women who completed surveys a year after treatment reported improved sexual function, a measure that reflects pain, desire, arousal and satisfaction. About nine in 10 had better overall quality of life, researchers said. "UFE [uterine fibroid embolization] is not a new intervention," said Dr. Marc Sapoval, one of the study co-authors. Sapoval is a professor of clinical radiology at Hopital Europeen Georges Pompidou in Paris. "What's new in this data is the fact that we focused on sexual function," he said. The study results were scheduled to be presented Sunday at the Society of Interventional Radiology's annual scientific ... Read more

Related support groups: Uterine Leiomyomata / Fibroids, Hypoactive Sexual Desire Disorder

Surgeons Perform First U.S. Uterus Transplant

Posted 26 Feb 2016 by Drugs.com

FRIDAY, Feb. 26, 2016 – Cleveland Clinic surgeons this week performed the nation's first uterus transplant, an experimental procedure offering women without a womb the possibility of pregnancy. The transplanted uterus came from a deceased donor, and the 26-year-old recipient was in stable condition following the nine-hour procedure, her doctors said Thursday. "Cleveland Clinic began screening candidates for uterus transplants late last year," according to a hospital news release. Women who might be candidates for such a transplant have ovaries but were either born without a uterus, have lost it or have suffered irreversible uterine damage, the hospital explained. The condition, called uterine factor infertility, affects 3 percent to 5 percent of women worldwide. One expert not involved in the procedure said it was a real advance for these patients. "The procedure is groundbreaking for ... Read more

Related support groups: Abnormal Uterine Bleeding, Delivery, Uterine Bleeding, Uterine Leiomyomata / Fibroids, Organ Transplant - Rejection Prophylaxis, Organ Transplant, Labor Pain, Diagnosis and Investigation, Cesarean Section, Rejection Prophylaxis, Body Imaging, Labor and Delivery including Augmentation

Hormones Tied to Uterine Fibroid Risk in Study

Posted 18 Dec 2015 by Drugs.com

FRIDAY, Dec. 18, 2015 – Having high levels of the hormones testosterone and estrogen in mid-life may boost a woman's risk of benign tumors in the uterus called uterine fibroids, a new study suggests. "Our findings are particularly interesting because testosterone was previously unrecognized as a factor in the development of uterine fibroids," study co-author Dr. Jennifer Lee, from Stanford University School of Medicine, said in a news release from the Endocrine Society. The study included nearly 1,400 women who had their testosterone and estrogen levels checked nearly every year for 13 years. Those with high levels of testosterone in their blood were 1.3 times more likely to develop uterine fibroids than those with low levels, and the risk was even greater in those with high levels of testosterone and estrogen, the investigators found. But while women with high levels of both hormones ... Read more

Related support groups: Female Infertility, Ultrasound, Uterine Leiomyomata / Fibroids, Diagnosis and Investigation

Doctors Rally in Support of Fibroid Device Curbed by FDA

Posted 8 Dec 2015 by Drugs.com

TUESDAY, Dec. 8, 2015 – Dozens of gynecologists, cancer doctors and women's health experts are challenging a U.S. Food and Drug Administration warning on a power device used to remove fibroid growths from a woman's uterus. The tool – a laparoscopic power morcellator – grinds up fibroid growths during minimally invasive surgery. The group of experts claim that curbing its use may force patients to undergo riskier, more invasive procedures. The FDA issued a "boxed warning" label on the devices last year. The agency had concluded that in about one out of every 458 cases, the morcellator chews up an undiagnosed cancerous growth and floods the woman's abdomen with cancer cells. But a review group of 46 experts says the FDA got its facts wrong. The likelihood that power morcellation would grind up a cancerous growth is actually much lower, they contend. "The best case scenario would be for ... Read more

Related support groups: Surgery, Hysterectomy, Uterine Leiomyomata / Fibroids, Gastrointestinal Surgery, Genitourinary Surgical and Other Conditions

Black Women Less Likely to Survive Uterine Cancer, Study Finds

Posted 19 Aug 2015 by Drugs.com

WEDNESDAY, Aug. 19, 2015 – Uterine cancer rates are rising in the United States, particularly among black and Asian women, according to a new study that also found black women are more likely to die of the disease. Researchers analyzed more than 120,000 cases of uterine cancer diagnosed in the United States between 2000 and 2011, and found that rates rose among all racial and ethnic groups. But rates increased fastest, at 2.5 percent a year, among black and Asian women. Black women also had higher rates of aggressive uterine cancer than Asian, Hispanic and white women, and death rates for aggressive uterine cancer were more than 1.5 times higher among black women than among white women. Death rates for aggressive uterine cancer were similar or lower among Asian and Hispanic women, compared to white women. A five-year analysis found that black women had poorer survival rates than white ... Read more

Related support groups: Cancer, Abnormal Uterine Bleeding, Uterine Bleeding, Uterine Leiomyomata / Fibroids, Endometrial Cancer

Low Cancer Risk With Device Used to Remove Fibroids, Study Finds

Posted 19 Feb 2015 by Drugs.com

THURSDAY, Feb. 19, 2015 – A small power tool that is sometimes used to remove fibroids in the uterus can end up spreading bits of hidden cancerous tumors throughout the abdomen, but a new study suggests the likelihood is low. Researchers called the findings, reported online Feb. 19 in JAMA Oncology, "reassuring." But the device, called a power morcellator, remains under restricted use. Until recently, doctors commonly used power morcellators during minimally invasive surgery to remove uterine fibroids – non-cancerous growths in the wall of the uterus. Fibroids are very common, but some women eventually need surgery to put an end to symptoms like pelvic pain and heavy menstrual bleeding. Doctors can either remove the fibroids or perform a hysterectomy to remove the uterus. The power morcellator has a rotating blade that breaks apart fibroid growths or, during a hysterectomy, the uterus ... Read more

Related support groups: Uterine Leiomyomata / Fibroids

FDA Adds 'Boxed Warning' to Devices Used to Remove Uterine Fibroids

Posted 24 Nov 2014 by Drugs.com

MONDAY, Nov. 24, 2014 – The U.S. Food and Drug Administration on Monday announced that new "boxed warning" labels will be added to devices called laparoscopic power morcellators, which are used to grind up uterine fibroid growths. The warning labels follow a recommendation issued in July by an FDA advisory panel that stated there's no way to guarantee surgical morcellation wouldn't increase the risk of spreading cancer to other parts of a woman's body. The new warning will let surgeons and patients know that "uterine tissue may contain unsuspected cancer [and] the use of laparoscopic power morcellators during fibroid surgery may spread cancer and decrease the long-term survival of patients," the FDA said in a news release. Two other warnings will state that the morcellators should not be used in patients who are in or around menopause or in most patients who would need to undergo ... Read more

Related support groups: Uterine Leiomyomata / Fibroids

J&J Pulls Hysterectomy Tool Tied to Cancer Risk From Market

Posted 31 Jul 2014 by Drugs.com

THURSDAY, July 31, 2014 – The largest maker of a surgical tool that has shown an increased risk of spreading undetected cancers in women has said it will withdraw its device from the market. In a letter that was to be sent to all of its customers Thursday, Johnson & Johnson asked that its laparoscopic power morcellators be returned to the company, the Wall Street Journal reported. Sales of new morcellators had been suspended in April after the U.S. Food and Drug Administration warned that doctors should not use the tool because of the potential risk of spreading cancer during minimally invasive surgeries to remove uterine fibroids, noncancerous growths on the uterus, or the uterus itself. The morcellator used a spinning power cutter to slice uterine tissue into smaller fragments. Those fragments were then removed through small incisions in the abdomen via a tube or laparoscope. Experts ... Read more

Related support groups: Uterine Leiomyomata / Fibroids

Technique Used in Some Hysterectomies May Help Spread Cancer: Study

Posted 22 Jul 2014 by Drugs.com

TUESDAY, July 22, 2014 – Removing the uterus with a minimally invasive procedure known as morcellation carries a risk of spreading undetected cancer, and now a new study pinpoints the likelihood more clearly. Twenty-seven of every 10,000 women who had the technique had undetected uterine cancer at the time of the procedure, researchers found, with the odds being highest for patients over the age of 65. Surgeons performing a hysterectomy with morcellation use a power cutter to slice uterine tissue into smaller fragments, and then remove those fragments through small incisions in the abdomen via a tube or laparoscope. "With this procedure, you are breaking up the uterus," said study researcher Dr. Jason Wright, chief of gynecologic oncology at the Columbia University College of Physicians and Surgeons in New York City. "You are essentially cutting through a cancer [if it is present] and ... Read more

Related support groups: Hysterectomy, Uterine Leiomyomata / Fibroids, Endometrial Cancer

FDA Advisers Weigh Risks of Procedure for Removal of Uterine Fibroids

Posted 14 Jul 2014 by Drugs.com

SATURDAY, July 12, 2014 – There's no way to guarantee that a surgical technique used to grind up uterine growths and remove them through tiny incisions won't increase the risk of spreading cancer to other parts of a woman's body, U.S. health advisers said Friday. The advisory panel to the Food and Drug Administration also said that women who do undergo the procedure – called laparoscopic power morcellation – should sign a written consent stating that they understand the potential risks, the Associated Press reported. The panel's advisory opinion follows an April 17 warning from the FDA that the procedure can inadvertently spread cancerous tissue beyond a woman's uterus and into other parts of her body. The FDA hasn't set a decision date on the use of power morcellator devices, the AP said. The agency isn't obliged to follow the advice or recommendations of its advisory committees but ... Read more

Related support groups: Uterine Leiomyomata / Fibroids

FDA Warns Against Procedure for Uterine Fibroids

Posted 18 Apr 2014 by Drugs.com

THURSDAY, April 17, 2014 – A surgical technique used to grind up uterine growths and remove them through tiny incisions could increase a woman's risk of cancer, the U.S. Food and Drug Administration warned Thursday. The FDA said that the procedure, known as "laparoscopic power morcellation," can inadvertently spread cancerous tissue beyond a woman's uterus and into other parts of her body. Surgeons frequently use laparoscopic power morcellation when they perform a hysterectomy or remove uterine fibroids, which are noncancerous growths on the smooth muscle tissue on the wall of the uterus. The minimally invasive procedure uses a power tool to chop up the tissue of the fibroids or, in the case of a hysterectomy, the uterus itself. These tissue fragments are then removed through tiny incisions, according to background information from the agency. The FDA estimates that about one in 350 ... Read more

Related support groups: Uterine Leiomyomata / Fibroids

Uterine Fibroids Take Heavy Toll on Women, Survey Finds

Posted 10 Oct 2013 by Drugs.com

THURSDAY, Oct. 10 – Women with uterine fibroids wait more than three years on average before seeking treatment, even though symptoms often interfere with their everyday lives, a new survey finds. These benign tumors affect up to 80 percent of women before the age of 50, and are the leading cause of hysterectomy – surgical removal of the uterus – in the United States. Nearly 1,000 women with fibroids responded to the Harris Interactive survey, and close to one-third of those with jobs said they missed work because of symptoms, including heavy or prolonged menstrual bleeding, cramping and fatigue. Many of the women expressed concern about fibroid treatment. More than three-quarters said they would prefer noninvasive approaches, more than half wanted to preserve their uterus, and younger women were often focused on preserving their fertility. "I was impressed by how strongly women felt ... Read more

Related support groups: Uterine Leiomyomata / Fibroids

Childhood Abuse May Be Tied to Uterine Fibroids: Study

Posted 30 Jan 2013 by Drugs.com

WEDNESDAY, Jan. 30 – Black women who suffered sexual or physical abuse as children may be at increased risk for uterine fibroids, a new study has found. Uterine fibroids – which can cause heavy menstrual bleeding, pelvic pain and infertility – are the most common type of benign tumor in women of childbearing age. "This is the second prospective study to show an association between childhood abuse and uterine fibroids diagnosed during adulthood," study leader Lauren Wise, senior epidemiologist at Boston University's Slone Epidemiology Center, said in a university news release. This association may be due to the effects of mental stress on sex steroid hormones, which are thought to be involved in fibroid development and growth, Wise said. In addition, child sexual abuse can lead to sexually transmitted infections, which may also increase fibroid risk, she explained in the news release. ... Read more

Related support groups: Uterine Leiomyomata / Fibroids

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Gynecological Conditions

Related Drug Support Groups

Lupron, Lupron Depot, leuprolide, Lupron Depot-Gyn, Lupron Depot 11.25 mg, Viadur, ulipristal